Research and Clinical Trials

Title  
Alliance A031102: A Randomized Phase III Trial Comparing Conventional-dose Chemotherapy using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-dose Chemotherapy using Mobilizing Paclitaxel plus Ifosfamide followed by High-dose Carboplatin and Etopos
Brief Description  
The primary objective of this study is to compare the overall survival in patients with relapsed or refractory Germ Cell Tumors being treated with conventional-dose chemotherapy verse those patients treated with high-dose chemotherapy plus Autologous Stem Cell Transplant (ASCT).
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Other Male Genital
Status  
OPEN
Start Date  
12/15/2016
IRB Number  
00018807
Principal Investigator  
Kaplan, Joel Adam
Contact Name  
Sceria Jenkins

For More Information, Contact  Sceria  , Jenkins
Phone:  980-442-2323 Fax:    
Email:  sceria.jenkins@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204
Close